Robeco Institutional Asset Management B.V. Biogen Inc. Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

A detailed history of Robeco Institutional Asset Management B.V. transactions in Biogen Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 274,708 shares of BIIB stock, worth $47.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

274,708

Previous 214,937 27.81%

Holding current value

$47.7 Million

Previous $49.8 Million 6.87%

% of portfolio

0.11%

Previous 0.11%

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$189.07 - $236.8 $11.3 Million - $14.2 Million	59,771 Added 27.81%	274,708 $53.2 Million
Q2 2024 Jul 22, 2024	SELL	$190.52 - $236.72 $3.16 Million - $3.92 Million	-16,579 Reduced 7.16%	214,937 $49.8 Million
Q1 2024 Apr 24, 2024	SELL	$212.02 - $267.71 $13.2 Million - $16.6 Million	-62,024 Reduced 21.13%	231,516 $49.9 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $29.4 Million - $35.4 Million	131,949 Added 81.66%	293,540 $76 Million
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $40.1 Million - $48.3 Million	-180,219 Reduced 52.72%	161,591 $294 Million
Q3 2023 Oct 23, 2023	SELL	$253.3 - $285.89 $356,393 - $402,247	-1,407 Reduced 0.41%	341,810 $87.8 Million
Q2 2023 Jul 24, 2023	SELL	$275.25 - $318.06 $5.02 Million - $5.8 Million	-18,230 Reduced 5.04%	343,217 $97.8 Million
Q1 2023 May 03, 2023	BUY	$256.56 - $292.34 $12.4 Million - $14.1 Million	48,290 Added 15.42%	361,447 $100 Million
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $1.35 Million - $1.64 Million	5,341 Added 1.74%	313,157 $86.7 Million
Q3 2022 Dec 01, 2022	BUY	$194.69 - $268.46 $24.6 Million - $33.9 Million	126,305 Added 69.59%	307,816 $82.2 Million
Q3 2022 Oct 26, 2022	BUY	$194.69 - $268.46 $24.6 Million - $33.9 Million	126,305 Added 69.59%	307,816 $82.2 Million
Q2 2022 Dec 01, 2022	BUY	$187.54 - $223.02 $734,219 - $873,123	3,915 Added 2.2%	181,511 $37 Million
Q2 2022 Jul 27, 2022	BUY	$187.54 - $223.02 $734,219 - $873,123	3,915 Added 2.2%	181,511 $37 Million
Q1 2022 Dec 01, 2022	SELL	$193.77 - $244.14 $2.65 Million - $3.34 Million	-13,669 Reduced 7.15%	177,596 $37.4 Million
Q1 2022 Apr 26, 2022	SELL	$193.77 - $244.14 $2.65 Million - $3.34 Million	-13,669 Reduced 7.15%	177,596 $37.4 Million
Q4 2021 Dec 01, 2022	BUY	$223.92 - $287.77 $4.28 Million - $5.5 Million	19,104 Added 11.1%	191,265 $45.9 Million
Q4 2021 Jan 31, 2022	BUY	$223.92 - $287.77 $4.28 Million - $5.5 Million	19,104 Added 11.1%	191,265 $45.9 Million
Q3 2021 Dec 01, 2022	BUY	$282.99 - $369.05 $2.18 Million - $2.85 Million	7,716 Added 4.69%	172,161 $48.7 Million
Q3 2021 Oct 20, 2021	BUY	$282.99 - $369.05 $2.18 Million - $2.85 Million	7,716 Added 4.69%	172,161 $48.7 Million
Q2 2021 Dec 01, 2022	SELL	$259.0 - $414.71 $28.8 Million - $46.1 Million	-111,144 Reduced 40.33%	164,445 $56.9 Million
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $28.8 Million - $46.1 Million	-111,144 Reduced 40.33%	164,445 $56.9 Million
Q1 2021 Dec 01, 2022	SELL	$242.95 - $284.63 $7.83 Million - $9.17 Million	-32,227 Reduced 10.47%	275,589 $77.1 Million
Q1 2021 Apr 23, 2021	SELL	$242.95 - $284.63 $11.9 Million - $13.9 Million	-48,910 Reduced 15.07%	275,589 $77.1 Million
Q4 2020 Dec 01, 2022	BUY	$236.26 - $355.63 $3.94 Million - $5.93 Million	16,683 Added 5.42%	324,499 $79.5 Million
Q4 2020 Jan 28, 2021	SELL	$236.26 - $355.63 $56.4 Million - $84.8 Million	-238,567 Reduced 42.37%	324,499 $79.5 Million
Q3 2020 Oct 29, 2020	BUY	$264.77 - $305.71 $42.5 Million - $49 Million	160,408 Added 39.84%	563,066 $160 Million
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $37 Million - $49.1 Million	143,210 Added 55.2%	402,658 $108 Million
Q1 2020 Apr 30, 2020	BUY	$268.85 - $341.04 $10.6 Million - $13.4 Million	39,407 Added 17.91%	259,448 $82.1 Million
Q4 2019 Jan 19, 2021	SELL	$220.06 - $304.07 $162,624 - $224,707	-739 Reduced 0.33%	220,041 $65.3 Million
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $3.65 Million - $5.04 Million	-16,575 Reduced 6.98%	220,780 $65.5 Million
Q3 2019 Jan 19, 2021	SELL	$217.44 - $243.88 $530,771 - $595,311	-2,441 Reduced 1.02%	237,355 $55.3 Million
Q3 2019 Oct 17, 2019	SELL	$217.44 - $243.88 $13.8 Million - $15.5 Million	-63,635 Reduced 20.97%	239,796 $55.8 Million
Q2 2019 Jan 19, 2021	SELL	$219.29 - $241.72 $470,157 - $518,247	-2,144 Reduced 0.7%	303,431 $71 Million
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $32 Million - $35.3 Million	-146,082 Reduced 32.34%	305,575 $71.5 Million
Q1 2019 Jan 19, 2021	SELL	$216.71 - $338.96 $434,936 - $680,292	-2,007 Reduced 0.44%	451,657 $107 Million
Q1 2019 May 02, 2019	BUY	$216.71 - $338.96 $17 Million - $26.7 Million	78,637 Added 20.97%	453,664 $107 Million
Q4 2018 Jan 19, 2021	SELL	$278.5 - $352.75 $257,612 - $326,293	-925 Reduced 0.25%	375,027 $113 Million
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $3.18 Million - $4.03 Million	11,436 Added 3.14%	375,952 $113 Million
Q3 2018 Jan 19, 2021	SELL	$293.51 - $383.83 $214,262 - $280,195	-730 Reduced 0.2%	364,516 $129 Million
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $140,004 - $183,086	477 Added 0.13%	365,246 $129 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $15.4 Million - $20.1 Million	-52,392 Reduced 12.56%	364,769 $129 Million
Q2 2018 Jan 19, 2021	SELL	$257.52 - $306.91 $337,351 - $402,052	-1,310 Reduced 0.31%	417,161 $121 Million
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $3.18 Million - $3.8 Million	-12,367 Reduced 2.87%	418,471 $121 Million
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $36.3 Million - $51.3 Million	139,562 Added 47.91%	430,838 $118 Million
Q4 2017 Jan 25, 2018	BUY	$307.64 - $344.58 $42.9 Million - $48.1 Million	139,529 Added 91.95%	291,276 $92.8 Million
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $32,613 - $38,244	116 Added 0.08%	151,747 $47.5 Million
Q2 2017 Aug 08, 2017	SELL	N/A	-4,072 Reduced 2.62%	151,631 $41.1 Million
Q1 2017 Jan 19, 2021	BUY	N/A	155,703	155,703 $42.6 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Biogen Inc. Transaction History